دورية أكاديمية
Post-COVID-19-Associated Multiorgan Complications or 'Long COVID' with Literature Review and Management Strategy Discussion: A Meta-Analysis
العنوان: | Post-COVID-19-Associated Multiorgan Complications or 'Long COVID' with Literature Review and Management Strategy Discussion: A Meta-Analysis |
---|---|
المؤلفون: | Iqbal, Phool, Ata, Fateen, Chaudhry, Hassan, Muthanna, Bassam, Waqas Younas, Hafiz, Munamm, Syed Ata Ul, Sharma, Rohit, Fadah, Kahtan, Elazzazy, Shereen, Hamad, Anas, Said Abu Tabar, Osama, Omar, Nabil E |
المصدر: | NYMC Residents/Fellows Publications |
بيانات النشر: | Touro Scholar |
سنة النشر: | 2023 |
المجموعة: | Touro College & University System: Touro Scholar |
مصطلحات موضوعية: | Resident/Fellow, Medicine and Health Sciences |
الوصف: | OBJECTIVE: To investigate the post-COVID-19 long-term complications or long COVID of various organ systems in patients after 3 months of the infection, specifically before the Omicron variant, with comparative literature analysis. METHODS: A systemic literature search and meta-analysis were conducted using multiple electronic databases (PubMed, Scopus, Cochrane library) with predefined search terms to identify eligible articles. Eligible studies reported long-term complications of COVID-19 infection before the Omicron variant infection. Case reports, case series, observational studies with cross-sectional or prospective research design, case-control studies, and experimental studies that reported post-COVID-19 complications were included. The complications reported after 3 months after the recovery from COVID-19 infection were included in the study. RESULTS: The total number of studies available for analysis was 34. The effect size (ES) for neurological complications was 29% with 95% confidence interval (CI): 19%-39%. ES for psychiatric complications was 24% with 95% CI: 7%-41%. ES was 9% for cardiac outcomes, with a 95% CI of 1%-18%. ES was 22%, 95% CI: 5%-39% for the gastrointestinal outcome. ES for musculoskeletal symptoms was 18% with 95% CI: 9%-28%. ES for pulmonary complications was 28% with 95% CI: 18%-37%. ES for dermatological complications was 25%, with a 95% CI of 23%-26%. ES for endocrine outcomes was 8%, with a 95% CI of 8%-9%. ES size for renal outcomes was 3% with a 95% CI of 1%-7%. At the same time, other miscellaneous uncategorized outcomes had ES of 39% with 95% CI of 21%-57%. Apart from analyzing COVID-19 systemic complications outcomes, the ES for hospitalization and intensive care unit admissions were found to be 4%, 95% CI: 0%-7%, and 11% with 95% CI: 8%-14%. CONCLUSION: By acquiring the data and statistically analyzing the post-COVID-19 complications during the prevalence of most virulent strains, this study has generated a different way of understanding COVID-19 and its complications for ... |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | unknown |
العلاقة: | https://touroscholar.touro.edu/nymc_res_pubs/302Test |
DOI: | 10.1002/hsr2.1211 |
الإتاحة: | https://doi.org/10.1002/hsr2.1211Test https://touroscholar.touro.edu/nymc_res_pubs/302Test |
رقم الانضمام: | edsbas.5939F6F |
قاعدة البيانات: | BASE |
DOI: | 10.1002/hsr2.1211 |
---|